MISSISSAUGA, ON, March 26, 2021 /PRNewswire/ - Nuvo
Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo
Healthcare (Miravo or the Company), a Canadian-focused healthcare
company with global reach and a diversified portfolio of commercial
products, today announced it has earned a spot on the 2021
Report on Business Women Lead Here list, an annual editorial
benchmark to identify best-in-class executive gender diversity in
corporate Canada.
Established in 2020 by Report on Business magazine, the Women
Lead Here initiative applies a proprietary research methodology to
determine Canadian corporations with the highest degree of gender
diversity among executive ranks.
"We are thrilled to be recognized in the Globe and Mail's Women
Lead Here benchmark of executive gender diversity. At Miravo,
we recognize the importance of leveraging the strengths,
experiences, and perspectives of women and this is critical to our
ongoing success. It is also incumbent on us to ensure our
organizational composition reflects the diversity of the healthcare
providers, patients and customers who rely on our medicines every
day," stated Jesse Ledger, President
& CEO of Miravo Healthcare.
For the 2021 ranking, Report on Business conducted a
journalistic analysis of nearly 500 large publicly traded Canadian
companies, evaluating the ratio of female-identifying to
male-identifying executives in the top three tiers of executive
leadership. The resultant data was applied to a weighted formula
that also factored in company performance, diversity and
year-to-year change.
In total, 71 companies earned the 2021 Women Lead Here seal,
with a combined average of 44% of executive roles held by
female-identifying individuals.
The full list of 2021 Women Lead Here honourees can be found in
the April issue of Report on Business magazine, distributed with
The Globe and Mail on Saturday, March
27th, and online now at tgam.ca/WomenLeadHere.
The strategies and ideas of winning companies will also be
showcased at the Women Lead Here webcast, taking place on
March 31, 2021. Event details and
registration information are available at
www.globeandmail.com/events.
About The Globe and Mail
The Globe and Mail is
Canada's foremost news media
company, leading the national discussion and causing policy change
through brave and independent journalism since 1844. With our
award-winning coverage of business, politics and national affairs,
The Globe and Mail newspaper reaches 5.9 million readers every week
in our print or digital formats, and Report on Business magazine
reaches 2.1 million readers in print and digital every issue. Our
investment in innovative data science means that as the world
continues to change, so does The Globe. The Globe and Mail is owned
by Woodbridge, the investment arm
of the Thomson family.
About Miravo Healthcare
Miravo is a Canadian focused,
healthcare company with global reach and a diversified portfolio of
commercial products. The Company's products target several
therapeutic areas, including pain, allergy, neurology and
dermatology. The Company's strategy is to in-license and
acquire growth-oriented, complementary products for Canadian and
international markets. Miravo's head office is located in
Mississauga, Ontario, Canada, the
international operations are located in Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The Varennes
facility operates in a Good Manufacturing Practices (GMP)
environment respecting the U.S, Canada and E.U. GMP regulations and is
regularly inspected by Health Canada and the U.S. Food and Drug
Administration. For additional information, please visit
www.miravohealthcare.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-acknowledged-in-the-globe-and-mails-second-annual-women-lead-here-benchmark-of-executive-gender-diversity-301256645.html
SOURCE Nuvo Pharmaceuticals Inc.